{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T08:41:42Z","timestamp":1794991302840,"version":"4.9.1"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Low-dose colchicine reduces the risk of cardiovascular events after myocardial infarction (MI). The purpose of this study was to assess the effect of colchicine post-MI on coronary plaque morphology in non-culprit segments by optical coherence tomography (OCT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>COCOMO-ACS was a double-blind, placebo-controlled trial that randomized 64 patients (median age 61.5 years; 9.4% female) with acute non-ST-segment elevation MI to colchicine 0.5\u2005mg daily or placebo for a median of 17.8 months in addition to guideline-recommended therapy. Participants underwent serial OCT imaging within a matched segment of non-culprit coronary artery that contained at least one lipid-rich plaque causing \u226520% stenosis. The primary outcome was the change in minimum fibrous cap thickness (FCT) in non-culprit segments from baseline to final visit. Of those randomized, 57 (29 placebo, 28 colchicine) had evaluable imaging at baseline and follow-up. Overall, colchicine had no effect on relative (placebo +48.0 \u00b1 35.1% vs. colchicine +62.4 \u00b1 38.1%, P = 0.18) or absolute changes in minimum FCT (+29.2 \u00b1 20.9\u2005\u00b5m vs. + 37.2 \u00b1 21.3\u2005\u00b5m, P = 0.18), or change in maximum lipid arc (\u221238.8 \u00b1 32.2\u00b0 vs. \u221254.8 \u00b1 46.9\u00b0, P = 0.18) throughout the imaged non-culprit segment. However, in patients assigned colchicine, cap rupture was less frequent (placebo 27.6% vs. colchicine 3.6%, P = 0.03). In post hoc analysis of 43 participants who had been followed for at least 16 months, minimum FCT increased to a greater extent in the colchicine group (placebo +38.7 \u00b1 25.4% vs. colchicine +64.7 \u00b1 34.1%, P = 0.005).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this study, OCT failed to detect an effect of colchicine on the minimum FCT or maximum lipid arc of plaques in non-culprit segments post-MI. The post hoc observation that minimum FCT increased to a greater extent with colchicine after more prolonged treatment suggests that longer-term studies may be required to detect the effect of anti-inflammatory therapies on plaque morphology by OCT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Australian New Zealand Clinical Trials Registry Identifier, ACTRN12618000809235, registered on the 11 May 2018.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cvr\/cvae191","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T02:23:02Z","timestamp":1724638982000},"page":"468-478","source":"Crossref","is-referenced-by-count":47,"title":["Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarction"],"prefix":"10.1093","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0222-5468","authenticated-orcid":false,"given":"Peter J","family":"Psaltis","sequence":"first","affiliation":[{"name":"Vascular Research Center, Lifelong Health Theme, South Australian Health and Medical Research Institute , North Terrace, Adelaide 5000 ,","place":["Australia"]},{"name":"Department of Cardiology, Central Adelaide Local Health Network , Port Road, Adelaide 5000 ,","place":["Australia"]},{"name":"Adelaide Medical School, University of Adelaide , North Terrace, Adelaide 5000 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mau T","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Vascular Research Center, Lifelong Health Theme, South Australian Health and Medical Research Institute , North Terrace, Adelaide 5000 ,","place":["Australia"]},{"name":"Department of Cardiology, Central Adelaide Local Health Network , Port Road, Adelaide 5000 ,","place":["Australia"]},{"name":"Adelaide Medical School, University of Adelaide , North Terrace, Adelaide 5000 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuljit","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Gold Coast University Hospital , Gold Coast ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Sinhal","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Flinders Medical Center , Adelaide ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis T L","family":"Wong","sequence":"additional","affiliation":[{"name":"Victorian Heart Institute, Monash University , Clayton ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Alcock","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Royal Perth Hospital , Perth ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmalar","family":"Rajendran","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Lyell McEwin Hospital , Adelaide ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rustem","family":"Dautov","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Prince Charles Hospital , Brisbane ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Barlis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Northern Hospital , Melbourne ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Royal Prince Alfred Hospital , Sydney ,","place":["Australia"]},{"name":"Heart Research Institute, The University of Sydney , Sydney ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thalia","family":"Salagaras","sequence":"additional","affiliation":[{"name":"Vascular Research Center, Lifelong Health Theme, South Australian Health and Medical Research Institute , North Terrace, Adelaide 5000 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A","family":"Marathe","sequence":"additional","affiliation":[{"name":"Vascular Research Center, Lifelong Health Theme, South Australian Health and Medical Research Institute , North Terrace, Adelaide 5000 ,","place":["Australia"]},{"name":"Department of Cardiology, Central Adelaide Local Health Network , Port Road, Adelaide 5000 ,","place":["Australia"]},{"name":"Adelaide Medical School, University of Adelaide , North Terrace, Adelaide 5000 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina A","family":"Bursill","sequence":"additional","affiliation":[{"name":"Vascular Research Center, Lifelong Health Theme, South Australian Health and Medical Research Institute , North Terrace, Adelaide 5000 ,","place":["Australia"]},{"name":"Adelaide Medical School, University of Adelaide , North Terrace, Adelaide 5000 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J","family":"Montarello","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Central Adelaide Local Health Network , Port Road, Adelaide 5000 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan M","family":"Nidorf","sequence":"additional","affiliation":[{"name":"Advara HeartCare, Western Australia , Perth ,","place":["Australia"]},{"name":"Cardiovascular Science and Diabetes Program, Harry Perkins Institute of Medical Research , Perth ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L","family":"Thompson","sequence":"additional","affiliation":[{"name":"Advara HeartCare, Western Australia , Perth ,","place":["Australia"]},{"name":"Cardiovascular Science and Diabetes Program, Harry Perkins Institute of Medical Research , Perth ,","place":["Australia"]},{"name":"Heart Research Institute, Sir Charles Gairdner Hospital , Perth ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Butters","sequence":"additional","affiliation":[{"name":"Victorian Heart Institute, Monash University , Clayton ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alana R","family":"Cuthbert","sequence":"additional","affiliation":[{"name":"SAHMRI Women & Kids, South Australian Health and Medical Research Institute , Adelaide ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa N","family":"Yelland","sequence":"additional","affiliation":[{"name":"SAHMRI Women & Kids, South Australian Health and Medical Research Institute , Adelaide ,","place":["Australia"]},{"name":"School of Public Health, The University of Adelaide , Adelaide ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanita L","family":"Ottaway","sequence":"additional","affiliation":[{"name":"Vascular Research Center, Lifelong Health Theme, South Australian Health and Medical Research Institute , North Terrace, Adelaide 5000 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6307-5593","authenticated-orcid":false,"given":"Yu","family":"Kataoka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center , Suita ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Di Giovanni","sequence":"additional","affiliation":[{"name":"Vascular Research Center, Lifelong Health Theme, South Australian Health and Medical Research Institute , North Terrace, Adelaide 5000 ,","place":["Australia"]},{"name":"Victorian Heart Institute, Monash University , Clayton ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J","family":"Nicholls","sequence":"additional","affiliation":[{"name":"Victorian Heart Institute, Monash University , Clayton ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"key":"2025042904113871200_cvae191-B1","first-page":"2525","article-title":"Inflammation during the life cycle of the atherosclerotic plaque","volume":"117","author":"Libby","year":"2021","journal-title":"Cardiovasc Res"},{"key":"2025042904113871200_cvae191-B2","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025042904113871200_cvae191-B3","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"2025042904113871200_cvae191-B4","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"2025042904113871200_cvae191-B5","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1161\/CIRCULATIONAHA.120.050771","article-title":"Colchicine in patients with acute coronary syndrome: the Australian COPS randomized clinical trial","volume":"142","author":"Tong","year":"2020","journal-title":"Circulation"},{"key":"2025042904113871200_cvae191-B6","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1093\/eurheartj\/ehab115","article-title":"Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials","volume":"42","author":"Fiolet","year":"2021","journal-title":"Eur Heart J"},{"key":"2025042904113871200_cvae191-B7","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology joint committee on clinical practice guidelines","volume":"148","author":"Virani","year":"2023","journal-title":"Circulation"},{"key":"2025042904113871200_cvae191-B8","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.21037\/cdt-20-1","article-title":"The role of intracoronary imaging in translational research","volume":"10","author":"Montarello","year":"2020","journal-title":"Cardiovasc Diagn Ther"},{"key":"2025042904113871200_cvae191-B9","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/CIRCULATIONAHA.122.060308","article-title":"Noninvasive plaque imaging to accelerate coronary artery disease drug development","volume":"146","author":"Figtree","year":"2022","journal-title":"Circulation"},{"key":"2025042904113871200_cvae191-B10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1002358","article-title":"A prospective natural-history study of coronary atherosclerosis","volume":"364","author":"Stone","year":"2011","journal-title":"N Engl J Med"},{"key":"2025042904113871200_cvae191-B11","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jacc.2012.10.054","article-title":"Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques","volume":"61","author":"Narula","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025042904113871200_cvae191-B12","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1001\/jama.2022.5218","article-title":"Effect of alirocumab added to high-intensity statin therapy on coronary atherosclerosis in patients with acute myocardial infarction: the PACMAN-AMI randomized clinical trial","volume":"327","author":"Raber","year":"2022","journal-title":"JAMA"},{"key":"2025042904113871200_cvae191-B13","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.jcmg.2022.03.002","article-title":"Effect of evolocumab on coronary plaque phenotype and burden in statin-treated patients following myocardial infarction","volume":"15","author":"Nicholls","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025042904113871200_cvae191-B14","doi-asserted-by":"crossref","first-page":"e22846","DOI":"10.1096\/fj.202201469R","article-title":"Colchicine exerts anti-atherosclerotic and -plaque-stabilizing effects targeting foam cell formation","volume":"37","author":"Schwarz","year":"2023","journal-title":"FASEB J"},{"key":"2025042904113871200_cvae191-B15","doi-asserted-by":"crossref","first-page":"898690","DOI":"10.3389\/fimmu.2022.898690","article-title":"Colchicine impacts leukocyte trafficking in atherosclerosis and reduces vascular inflammation","volume":"13","author":"Meyer-Lindemann","year":"2022","journal-title":"Front Immunol"},{"key":"2025042904113871200_cvae191-B16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.athplu.2021.08.008","article-title":"Colchicine reduces atherosclerotic plaque vulnerability in rabbits","volume":"45","author":"Roubille","year":"2021","journal-title":"Atheroscler Plus"},{"key":"2025042904113871200_cvae191-B17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jcmg.2017.08.013","article-title":"Colchicine therapy and plaque stabilization in patients with acute coronary syndrome: a CT coronary angiography study","volume":"11","author":"Vaidya","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025042904113871200_cvae191-B18","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"2025042904113871200_cvae191-B19","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s10557-021-07240-9","article-title":"Assessing the impact of colchicine on coronary plaque phenotype after myocardial infarction with optical coherence tomography: rationale and design of the COCOMO-ACS study","volume":"36","author":"Montarello","year":"2022","journal-title":"Cardiovasc Drugs Ther"},{"key":"2025042904113871200_cvae191-B20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.21037\/cdt-20-684","article-title":"Assessing the impact of PCSK9 inhibition on coronary plaque phenotype with optical coherence tomography: rationale and design of the randomized, placebo-controlled HUYGENS study","volume":"11","author":"Nicholls","year":"2021","journal-title":"Cardiovasc Diagn Ther"},{"key":"2025042904113871200_cvae191-B21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/eurheartj\/ehz520","article-title":"Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: the CLIMA study","volume":"41","author":"Prati","year":"2020","journal-title":"Eur Heart J"},{"key":"2025042904113871200_cvae191-B22","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.jacc.2014.08.045","article-title":"Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography: the EASY-FIT study","volume":"64","author":"Komukai","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025042904113871200_cvae191-B23","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","article-title":"Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials","volume":"401","author":"Ridker","year":"2023","journal-title":"Lancet"},{"key":"2025042904113871200_cvae191-B24","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/cvr\/cvaa211","article-title":"Inflammation and cardiovascular diseases: lessons from seminal clinical trials","volume":"117","author":"Liberale","year":"2021","journal-title":"Cardiovasc Res"},{"key":"2025042904113871200_cvae191-B25","doi-asserted-by":"crossref","first-page":"e002128","DOI":"10.1161\/JAHA.115.002128","article-title":"Colchicine acutely suppresses local cardiac production of inflammatory cytokines in patients with an acute coronary syndrome","volume":"4","author":"Martinez","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"2025042904113871200_cvae191-B26","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41569-022-00687-9","article-title":"Optical coherence tomography in coronary atherosclerosis assessment and intervention","volume":"19","author":"Araki","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"2025042904113871200_cvae191-B27","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jacc.2023.01.030","article-title":"Identification of high-risk coronary lesions by 3-vessel optical coherence tomography","volume":"81","author":"Jiang","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2025042904113871200_cvae191-B28","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1161\/CIRCULATIONAHA.121.054610","article-title":"Colchicine in patients with acute coronary syndrome: two-year follow-up of the Australian COPS randomized clinical trial","volume":"144","author":"Tong","year":"2021","journal-title":"Circulation"},{"key":"2025042904113871200_cvae191-B29","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/CIRCULATIONAHA.119.044720","article-title":"Low-attenuation noncalcified plaque on coronary computed tomography angiography predicts myocardial infarction: results from the multicenter SCOT-HEART trial (Scottish Computed Tomography of the HEART)","volume":"141","author":"Williams","year":"2020","journal-title":"Circulation"},{"key":"2025042904113871200_cvae191-B30","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1093\/cvr\/cvaa342","article-title":"Colchicine in coronary disease: another renaissance of an ancient drug","volume":"117","author":"Fiolet","year":"2021","journal-title":"Cardiovasc Res"},{"key":"2025042904113871200_cvae191-B31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijcard.2022.06.028","article-title":"Low-dose colchicine and high-sensitivity C-reactive protein after myocardial infarction: a combined analysis using individual patient data from the COLCOT and LoDoCo-MI studies","volume":"363","author":"Sun","year":"2022","journal-title":"Int J Cardiol"},{"key":"2025042904113871200_cvae191-B32","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.clinthera.2019.07.015","article-title":"Colchicine as a novel therapy for suppressing chemokine production in patients with an acute coronary syndrome: a pilot study","volume":"41","author":"Tucker","year":"2019","journal-title":"Clin Ther"},{"key":"2025042904113871200_cvae191-B33","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/1074248420922793","article-title":"A MicroRNA signature in acute coronary syndrome patients and modulation by colchicine","volume":"25","author":"Barraclough","year":"2020","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"2025042904113871200_cvae191-B34","doi-asserted-by":"crossref","first-page":"e018993","DOI":"10.1161\/JAHA.120.018993","article-title":"Colchicine inhibits neutrophil extracellular trap formation in patients with acute coronary syndrome after percutaneous coronary intervention","volume":"10","author":"Vaidya","year":"2021","journal-title":"J Am Heart Assoc"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cardiovascres\/advance-article-pdf\/doi\/10.1093\/cvr\/cvae191\/59032508\/cvae191.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/121\/3\/468\/59032508\/cvae191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/121\/3\/468\/59032508\/cvae191.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T04:11:50Z","timestamp":1745899910000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/121\/3\/468\/7742399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,8,27]]},"published-print":{"date-parts":[[2025,4,29]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvae191","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,8,27]]}}}